ClinicalTrials.gg
Sign In

Leukemia, Plasma Cell clinical trials

The registry lists 60 studies for Leukemia, Plasma Cell across more than 10 countries. 33 are recruiting or about to start. 47 of them are mainly about Leukemia, Plasma Cell (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.

Get an email when these change. Save the Leukemia, Plasma Cell studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Recruiting
29
Completed
16
Not yet recruiting
4
Status unknown
3
Active, not recruiting
3
Terminated
3

Phase

Phase 2
32
Phase 1
18
Early Phase 1
6
Phase 3
1

Where

United States
31
China
20
Italy
3
Greece
2
Czechia
1
Serbia
1

Who runs them

Institute of Hematology & Blood Diseases Hospital, China (9) · Masonic Cancer Center, University of Minnesota (5) · M.D. Anderson Cancer Center (4) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2) · City of Hope Medical Center (2) · Fred Hutchinson Cancer Center (2) · National Cancer Institute (NCI) (2) · The First Affiliated Hospital of Soochow University (2)

What is being tested here

Drugs under test in Leukemia, Plasma Cell studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Fludarabine207
Cyclophosphamide205
Teclistamab212
Fludarabine phosphate104
Mycophenolic Acid103
Lenalidomide113
Allopurinol102
Daratumumab102
Isatuximab101
CM336101

Drug classes tested here Alkylating agents 2 open · Antimetabolites 2 open · Corticosteroids 1 open · Proteasome inhibitors 8

Coming up

1phase 3 study under way
12studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 29 Leukemia, Plasma Cell studies recruiting now, 12 (41%) set no upper age limit and 13 (45%) stop at 75 or younger. 4 (14%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (3%) take healthy volunteers.

Recruiting studies that take each age, of 29
AgeWomenMen
103 (10%)3 (10%)
1827 (93%)27 (93%)
3028 (97%)28 (97%)
4028 (97%)28 (97%)
5029 (100%)29 (100%)
6528 (97%)28 (97%)
7526 (90%)26 (90%)
8512 (41%)12 (41%)

Across all 60 studies, recruiting or not: 48% stop at 75 or younger and 10% at 65; 17% take children; 0% are for women only and 0% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 60. Browse all 60 → or search them.